Method for treating transplant patients using mycalamide compounds
US5298523A · kind A · utility
8Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 1992 |
| Grant date | Mar 29, 1994 |
| Priority date | — |
| Expiry date | Dec 14, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F7/1804
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mycalamide compounds are derived from marine sponges of the genus Mycale or prepared by synthetic methods. These compounds, and pharmaceutical compositions containing them as active ingredients, are useful as immunomodulatory agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.